Series date: 
07/01/2021 - 7:00am CDT to 06/30/2022 - 4:00pm CDT

Please check the individual session for location or broadcast availability.  



Series Co-directors

Sagar Dhamne, MBBS, MD

James Dunn-Urbonas, PhD

Target Audience and Needs

Pathologists, residents, fellows, and pathology assistants need to be updated on topics related to ancillary molecular or genomic testing and how it is increasingly impacting patient care across all medical specialties. To help guide testing and interpretation, pathologists must be knowledgeable about these new techniques and their clinical utility. Many currently practicing pathologists have been trained without any exposure to molecular or genomics testing and, hence, need education in these areas. Additionally, laboratories are required to balance competing demands of controlling costs (while maintaining or improving quality) and addressing the need for increased access to newer expensive technologies. It is necessary to educate pathologists to help develop effective test utilization strategies across the health care system.

Educational Methods

Educational methods may include lectures.


At the conclusion of the sessions, the participants should be able to:

  • Compare recent laboratory techniques developed to detect drug-resistant organisms, and appraise research evaluating the feasibility, effectiveness, and impact of these tests.
  • Incorporate historical and longitudinal clinical laboratory test results to develop targeted disease-state interventions in clinical workflows.
  • Apply optimal grossing strategies for pancreatic cancer specimens, including neoadjuvant-treated specimens, to guide accurate classification and staging.
  • Outline the authority structure of hospitals with respect to the stature of pathologists, and participate in administrative opportunities to influence hospital activities affecting pathology practice.
  • Apply knowledge of the biology of blood transfusion reactions, and implement an interdisciplinary team approach to safety checks to eliminate risk of preventable adverse transfusion events.


Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator 

Letha Middleton

Series location: 
Baylor College of Medicine
One Baylor Plaza
Houston, TX 77030
United States